Posts by KCAS Bio

KCAS-blog-thumb_2024-011_PBSS November 15 - November 15

KCAS Bio is excited to sponsor the upcoming Pharmaceutical & BioScience Society (PBSS) workshop, “Current State of Bioanalysis for Biologics and Cell/Gene Therapy Products: Refining Established Approaches for New Complex Therapies,” in Foster City, California. Dawn Dufield, Ph.D., will be presenting “Bioanalysis for Biologics and Cell/Gene Therapy Products…

KCAS-webinar-thumb_2024-09_Spectral Unmixing Webinar Webinars
View webinar KCAS Bio Webinar: Spectral Unmixing Impact Comparison Across Immunophenotyping Panels and Matrices

Webinar Description: KCAS Bio will present results from a recent validation of two IP panels on the Cytek Aurora in PBMCs. We have analyzed the impact of different fixation buffers on the efficacy of reference controls over time, and we will explore how to help improve workflow standards and process…

KCAS-blog-thumb_2024-010_1vision Blogs
Read article Global Harmonization of Spectral Flow Cytometry

KCAS Bio has embarked on a global initiative to harmonize its spectral flow cytometry services across four labs in three countries, collaborating with Crux Biolabs and Cytek Biosciences. This effort ensures standardized flow cytometry services across sites in the U.S., Europe, and Australia. As trials increasingly span multiple regions, global…

KCAS-blog-thumb_2024-09_USevents1 Blogs
Read article KCAS Bio’s October Roadshow

KCAS Bio is excited to announce our participation in several premier conferences throughout the United States this fall. These events bring together experts, innovators, and leaders in pharmaceuticals, biotechnology, and clinical research to exchange insights, explore the latest technologies, and drive the future of scientific discovery. As a trusted provider…

KCAS-blog-thumb_2024-09_LyonEmailBlog Blogs
Read article KCAS Bio Attending a Series of Premier Global Conferences in 2024

KCAS Bio is excited to announce our participation in several key conferences throughout the world. These events present invaluable opportunities for collaboration, innovation, and the sharing of industry insights. As a leading provider of bioanalytical services, KCAS Bio is committed to engaging with thought leaders, scientists, and professionals worldwide to…

KCAS-event-thumb_2024-09_ICCS October 4 - October 8

KCAS Bio is excited to announce our participation in the 39th International Clinical Cytometry Meeting and Course (ICCS), taking place in Seattle, Washington. This prestigious event will bring together global experts in cytometry to explore the latest advancements in clinical applications, research, and innovation. As a leader in bioanalytical services,…

KCAS-event-thumb_2024-09_BioJapan October 9 - October 11

KCAS Bio is thrilled to participate in BioJapan 2024, one of Asia’s most prominent biotechnology events, held in Yokohama, Japan. As a leader in bioanalytical and contract research services, our presence at BioJapan underscores our commitment to providing world-class solutions to the global biotech industry. This event offers an unparalleled…

KCAS-webinar-thumb_2024-09_Hybrid LC-MS_MS Webinars
View webinar Hybrid LC-MS/MS Technology Becoming the New Norm in the Bioanalysis of Antibody-Drug Conjugates

As the pharmaceutical industry continues to evolve, so does the technology behind drug development. One of the most groundbreaking advancements in bioanalysis is Hybrid LC-MS/MS technology, which is rapidly becoming the new standard for analyzing Antibody Drug Conjugates (ADCs). KCAS Bio is proud to be at the forefront of this…

KCAS-event-thumb_2024-09_AusBiotech October 30 - November 1

KCAS Bio is excited to announce our attendance at AusBiotech 2024 in Melbourne, Australia. As a leader in bioanalytical services, we are committed to supporting the growth and innovation of the biotech industry. This premier event offers a unique platform to engage with industry experts, innovators, and decision-makers, all working…

KCAS-blog-thumb_2024-07_The Role Dose Form Plays Blogs
Read article The Role Dose Form Plays in Preclinical Studies

Preclinical formulation analysis supports toxicity studies before and after the investigational new drug application (IND). Multiple analytical studies support drug development progression beyond the IND stage. KCAS Bio performs analytical studies for a variety of clients. How Does KCAS Bio Perform Preclinical Formulation Analysis? KCAS Bio has completed numerous studies…

KCAS-blog-webinar_2024-08_ Anti-Drug Antibodies Testing Webinars
View webinar KCAS Bio’s Webinar on Anti-Drug Antibodies Testing

In the dynamic field of biotherapeutics, understanding and managing anti-drug antibodies (ADAs) is critical for the success of drug development programs. ADAs can potentially neutralize the efficacy of biotherapeutic drugs, making it essential to have robust testing methodologies in place from the preclinical to clinical stages. KCAS Bio is excited…

KCAS-blog-webinar_2024-08_ considerations for conventional and spectral flow Webinars
View webinar Evolving Best Practices: Considerations for Conventional and Spectral Flow

In the fast-paced world of drug development, the ability to produce accurate and reproducible data is paramount. That’s why staying updated with the latest best practices in flow cytometry is crucial. Our webinar, “Evolving Best Practices: Considerations for Conventional and Spectral Flow,” dives deep into the rapidly advancing field of…